Lobe Sciences Ltd. (CVE:LOBE)

PRESS RELEASE

published on 07/29/2025 at 06:08, 4 months 19 days ago

Lobe Sciences Ltd. Engages ArcStone Securities for Strategic Capital Markets Advisory
Lobe Sciences partners with ArcStone Securities to enhance capital market strategy, aiming to increase visibility and deliver shareholder value through scientific innovation and strategic collaboration in North American markets

Capital Markets Biopharmaceutical Investment Community Lobe Sciences ArcStone Securities
BRIEF

published on 07/17/2025 at 04:00, 5 months ago

Lobe Sciences Ltd. règle sa dette avec Gibbsons PC

Règlement De La Dette Traitements Innovants Émission D'actions Ordinaires Société Biopharmaceutique Valeurs Mobilières Canadiennes
BRIEF

published on 07/17/2025 at 04:00, 5 months ago

Lobe Sciences Ltd. Settles Debt with Gibbsons P.C.

Common Shares Issuance Debt Settlement Biopharmaceutical Company Canadian Securities Innovative Treatments
PRESS RELEASE

published on 07/17/2025 at 03:55, 5 months ago

Lobe Sciences Ltd. Announces Debt Settlement
Lobe Sciences settles debt with Gibbsons Law P.C. by issuing 546,206 common shares at CAD$0.02123/share. The shares were issued on May 13, 2025, subject to regulatory hold periods

Common Shares Debt Settlement Biopharmaceutical Lobe Sciences Regulatory Hold Periods
BRIEF

published on 07/08/2025 at 06:06, 5 months 9 days ago

Lobe Sciences Secures European Patent for Sickle Cell Disease Treatment

European Patent Sickle Cell Disease DHA Composition Altemia® Biopharmaceutical Expansion
BRIEF

published on 07/08/2025 at 06:06, 5 months 9 days ago

Lobe Sciences obtient un brevet européen pour un traitement contre la drépanocytose

Brevet Européen Drépanocytose Altemia® Composition Du DHA Expansion Biopharmaceutique
PRESS RELEASE

published on 07/08/2025 at 06:01, 5 months 9 days ago

Lobe Sciences Announces Validation of European Unitary Patent for DHA-Based Composition for Sickle Cell Disease
Lobe Sciences secures European Unitary Patent EP4117446 across 17 EU member states for innovative Altemia(R) Medical Food Formula designed to manage Sickle Cell Disease, supporting global expansion strategy

Global Expansion Lobe Sciences Sickle Cell Disease European Unitary Patent Altemia Medical Food Formula
BRIEF

published on 06/18/2025 at 06:03, 5 months 29 days ago

Lobe Sciences fait progresser le développement de la psilocine conjuguée avec Cynaptec Spin-Out

Cynaptec Pharmaceuticals Psilocine Conjuguée Céphalées En Grappe Chroniques Drépanocytose Investissements Biopharmaceutiques
BRIEF

published on 06/18/2025 at 06:03, 5 months 29 days ago

Lobe Sciences Advances Conjugated Psilocin Development with Cynaptec Spin-Out

Conjugated Psilocin Cynaptec Pharmaceuticals Chronic Cluster Headaches Sickle Cell Disease Biopharmaceutical Investments
PRESS RELEASE

published on 06/18/2025 at 05:58, 5 months 29 days ago

Lobe Sciences Moves Forward with Development of Conjugated Psilocin(TM) Following April 14 Agreement to Spin Out Compound to Cynaptec Pharmaceuticals
Lobe Sciences Ltd. advances Conjugated Psilocin™ research for chronic cluster headaches and addiction via $6M investment in Cynaptec Pharmaceuticals, with option for additional $20M

Clinical Trials Investment Cynaptec Pharmaceuticals Lobe Sciences Ltd. Conjugated Psilocin™

Published on 12/17/2025 at 15:00, 7 hours 5 minutes ago

BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 8 hours 5 minutes ago

UniDoc Completes H3 Health Cube Installation in Italy
Published on 12/17/2025 at 13:35, 8 hours 30 minutes ago

Silver X Mining Announces Grant of Incentive Stock Options and Restricted Share Units
Published on 12/17/2025 at 13:15, 8 hours 50 minutes ago

Aclara Wins UN Global Compact Award for Its Contribution to Local Employment and Suppliers
Published on 12/17/2025 at 13:00, 9 hours 5 minutes ago

Gold Terra Provides a Summary of 2025 Achievements and 2026 Plan

View all ACCESSWIRE

Published on 12/17/2025 at 21:22, 43 minutes ago

EQS-Adhoc: DATAGROUP SE: DATAGROUP SE Management Board plans dividend of EUR 0.04 per share
Published on 12/17/2025 at 20:12, 1 hour 53 minutes ago

EQS-Adhoc: Rheinmetall AG: Executive Board decides to sell activities of the civil division Power Systems – Target is sale in the first quarter of 2026; update of outlook for continuing operation
Published on 12/17/2025 at 19:39, 2 hours 26 minutes ago

Avolta awarded Shanghai Pudong International Airport concession, marking a first-in-a-generation duty-free win for an international operator in mainland China
Published on 12/17/2025 at 19:10, 2 hours 55 minutes ago

Holand Automotive Group Announces the sale of Ferrari Rancho Mirage to Lapis Automotive Group
Published on 12/17/2025 at 18:39, 3 hours 26 minutes ago

EQS-Adhoc: centrotherm international AG: Centrotherm AcquiCo AG submits request for the squeeze-out of minority shareholders of centrotherm international AG

View all EQS

Published on 12/17/2025 at 20:39, 1 hour 26 minutes ago

Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 1 hour 26 minutes ago

Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 2 hours 35 minutes ago

Change in the composition of the Board
Published on 12/17/2025 at 19:30, 2 hours 35 minutes ago

Evolution de la composition du Conseil d’Administration
Published on 12/17/2025 at 18:00, 4 hours 5 minutes ago

Outstanding Shares and Voting Rights Statement at 30 November 2025

View all LES ECHOS COMFI WIRE

News